Kroger has announced an expansion to its rewards program, offering members more flexibility in how they redeem points. Customers can now choose to redeem their points for dollars off groceries, both in-store and online, in addition to the existing fuel discounts at the pump. The program also highlights ways to earn points faster, including special promotional offers and benefits for Boost members.

The Kroger Co.'s Board of Directors has approved an 11% increase in its quarterly dividend, raising it from $1.40 to $1.56 per year. The next quarterly dividend of 39 cents per share will be paid on September 1, 2026, marking the 20th consecutive year of dividend increases for the company. This decision reflects the Board's confidence in Kroger's operating performance, free cash flow generation, and commitment to delivering long-term shareholder value.

JPMorgan Chase has appointed Doug Petno and Troy Rohrbaugh as co-presidents, positioning them as potential successors to current CEO Jamie Dimon, who is 70 years old. This move by the country's largest bank signals a strategic succession planning process.

Dominion Energy (D) stock is currently trading at its fair value of $69 based on backward-looking analyst models. However, an upcoming $66.8 billion all-stock merger with NextEra Energy suggests a potential re-rating to $93, representing a 34% total return. While analysts maintain a "Hold" consensus due to regulatory approval uncertainties, the deal includes a protective $2.24 billion termination fee, and the combined entity is projected to achieve 9%+ combined EPS growth.

Royal Caribbean Group has announced a new partnership with Roald Dahl's Marvellous Children's Charity, coinciding with the European debut of its new ship, Legend of the Seas, which will feature the Broadway musical "Charlie and the Chocolate Factory." The collaboration aims to raise funds and awareness for specialist Roald Dahl Nurses who support seriously ill children and their families across the UK. Onboard initiatives and fundraising events during the ship's inaugural European season will contribute to the charity's network of over 250 nurses.

GE HealthCare Technologies Inc. (GEHC) is expanding its leadership in healthcare technology by focusing on AI-powered imaging solutions to meet evolving demands in radiology and nuclear medicine. The company recently showcased its latest innovations, including the Genesis Radiology Workspace and cloud-based offerings, at industry meetings. GEHC aims to enhance productivity, broaden access to advanced diagnostics, and improve clinical decision-making by integrating imaging technologies with AI-driven workflow solutions globally.

Dollar Tree (DLTR) announced its intention to repurchase $500 million in stock after investors linked to Mantle Ridge LP launched a secondary block trade to sell 12.8 million shares. The sale, facilitated by J.P. Morgan and Goldman Sachs, will reduce Mantle Ridge's stake in the discount retailer.

McCormick & Co. reported higher fiscal second-quarter sales of $1.94 billion, a 17% increase, surpassing Wall Street expectations. This comes as the company continues its integration efforts with Unilever’s food business. Despite the sales growth, net income for the quarter decreased to $150.1 million from $175 million in the prior year.

American Funds New Perspective (ANWPX) maintains a strong rating due to its experienced management team and consistent investment approach, even amidst a planned leadership transition. The fund has a proven track record of outperforming its benchmark and protecting capital during downturns, making it a reliable global equity option for long-term investors. Its focus on financially stable, multinational companies continues to deliver strong results, despite occasional short-term lags against growth indexes.

Seres Therapeutics announced it will host a webcast on July 8, 2026, to present top-line results from an investigator-sponsored trial (IST) of SER-155. The trial evaluated SER-155 for the treatment of immune checkpoint inhibitor-related enterocolitis (irEC), a severe side effect of cancer therapy, at Memorial Sloan Kettering Cancer Center. The webcast will discuss the potential of SER-155 to offer an immunosuppressive-free treatment alternative for patients with moderate to severe irEC.